In Situ Gelling Liquid Crystalline System as Local siRNA Delivery System (2017)
Source: Molecular Pharmaceutics. Unidades: IF, FCFRP
Subjects: CRISTAIS LÍQUIDOS, RNA, TECNOLOGIA FARMACÊUTICA, NANOTECNOLOGIA, BIOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGHETI-CARDOSO, Lívia Neves et al. In Situ Gelling Liquid Crystalline System as Local siRNA Delivery System. Molecular Pharmaceutics, v. 14, n. 5, p. 1681–1690, 2017Tradução . . Disponível em: https://doi.org/10.1021/acs.molpharmaceut.6b01141. Acesso em: 11 nov. 2024.APA
Borgheti-Cardoso, L. N., Kooijmans, S. A. A., Fens, M. H. A. M., Meel, R. van der, Vicentini, F. T. M. -de-C., Fantini, M. C. de A., et al. (2017). In Situ Gelling Liquid Crystalline System as Local siRNA Delivery System. Molecular Pharmaceutics, 14( 5), 1681–1690. doi:10.1021/acs.molpharmaceut.6b01141NLM
Borgheti-Cardoso LN, Kooijmans SAA, Fens MHAM, Meel R van der, Vicentini FTM-de-C, Fantini MC de A, Bentley MVLB, Schiffelers RM. In Situ Gelling Liquid Crystalline System as Local siRNA Delivery System [Internet]. Molecular Pharmaceutics. 2017 ; 14( 5): 1681–1690.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1021/acs.molpharmaceut.6b01141Vancouver
Borgheti-Cardoso LN, Kooijmans SAA, Fens MHAM, Meel R van der, Vicentini FTM-de-C, Fantini MC de A, Bentley MVLB, Schiffelers RM. In Situ Gelling Liquid Crystalline System as Local siRNA Delivery System [Internet]. Molecular Pharmaceutics. 2017 ; 14( 5): 1681–1690.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1021/acs.molpharmaceut.6b01141